DLH Announces Executive Appointments
July 13 2020 - 2:00PM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a
leading healthcare and human services provider to the federal
government, today announced executive leadership appointments
effective July 13, 2020. Jeanine Christian joins DLH as President,
Social & Scientific Systems (“S3”), and Jacqueline Everett is
appointed as DLH Chief Growth Officer.
In her role as President of the Company’s S3
operating unit, Ms. Christian succeeds Kevin Beverly and will lead
operations focused on the Public Health and Life Sciences market.
Having spent over 20 years in science-based organizations, she most
recently led a team of over 300 scientists, clinicians,
researchers, and data analysts whose mission it was to translate
scientific discovery and technology advances into societal benefits
for federal and state government, non-profit, academic, and
commercial clients. Ms. Christian’s last role was Vice President
& Business Line Manager of the Public Health Research Division
with Battelle Memorial Institute. Prior to that, she directed
various impactful research programs as a Senior Study Director at
Westat. As S3 President, her responsibilities will include
strategic direction of the operating unit, customer relationship
management, program execution, human resources, and generating
business growth.
Ms. Everett joins DLH as Chief Growth Officer.
In this role, she will spearhead enterprise-wide business
development activities, establishing the vision, direction, and
strategy required to achieve the Company’s growth objectives. She
brings over 25 years of successful experience in the government
contracting industry, most recently as Vice President Business
Development & Strategy with Leidos. Prior to that, she held
business development leadership positions with DXC Technology, CSC
and Serco.
“I am proud to announce these changes to our
leadership structure, which we are confident will enable DLH to
further capitalize on our highly-talented workforce, broad
capabilities, and longstanding demand for the services we provide,”
said DLH President and CEO Zach Parker. “Jeanine’s scientific
expertise, customer relationships, effective leadership, and
results-oriented approach to business make her a fantastic fit for
DLH. At the same time, Jackie Everett is recognized throughout our
industry as an accomplished, dynamic leader. Her drive, motivation,
and experience are expected to enable DLH to execute our strategic
vision. I am pleased that both are joining us at this critical time
in our growth trajectory.
“I also want to thank Kevin Beverly for his
leadership and for being an invaluable partner throughout the
acquisition and integration of S3 into DLH. With Kevin at the helm,
S3 grew to be a leading public health service organization
providing solutions in clinical and biomedical research,
epidemiology, health policy, and program evaluation. He will remain
on board in an advisory role to support us in this transition; we
are grateful for his many contributions and wish him all the best
as he writes his next chapter.”
About DLHDLH (NASDAQ:DLHC)
serves federal government clients throughout the United States and
abroad delivering technology enabled solutions in key health and
human services programs. The Company's seven core competencies
include secure data analytics, clinical trials and laboratory
services, case management, performance evaluation, system
modernization, operational logistics and readiness, and strategic
digital communications. DLH has over 1,950 employees serving
numerous government agencies. For more information, visit the
corporate website at www.dlhcorp.com.
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995:
This press release may contain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements relate to future events or
DLH`s future financial performance. Any statements that refer
to expectations, projections or other characterizations of future
events or circumstances or that are not statements of historical
fact (including without limitation statements to the effect that
the Company or its management “believes”, “expects”, “anticipates”,
“plans”, “intends” and similar expressions) should be considered
forward looking statements that involve risks and uncertainties
which could cause actual events or DLH’s actual results to differ
materially from those indicated by the forward-looking statements.
These statements reflect our belief and assumptions as to future
events that may not prove to be accurate. Our actual results may
differ materially from such forward-looking statements made in this
release due to a variety of factors. For a discussion of such risks
and uncertainties which could cause actual results to differ from
those contained in the forward-looking statements, see “Risk
Factors” in the Company’s periodic reports filed with the SEC,
including our Annual Report on Form 10-K for the fiscal year ended
September 30, 2019, and subsequent filings we make with the
SEC from time to time. The forward-looking statements contained
herein are not historical facts, but rather are based on current
expectations, estimates, assumptions and projections about our
industry and business. Such forward-looking statements are
made as of the date hereof and may become outdated over time. The
Company does not assume any responsibility for updating
forward-looking statements, except as may be required by law.
INVESTOR RELATIONSContact:
Chris WittyPhone: 646-438-9385Email:
cwitty@darrowir.com
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Jul 2023 to Jul 2024